Literature DB >> 2428283

Phenytoin: mechanisms of its anticonvulsant action.

Y Yaari, M E Selzer, J H Pincus.   

Abstract

Phenytoin is a major anticonvulsant drug that is very effective in controlling a wide variety of seizure disorders while impairing neurological function little, if at all. Early work suggested the hypothesis that the drug's effects were due to a selective block of high-frequency neuronal activity. This theory is reevaluated in the light of accumulated observations on the effects of phenytoin in many neuronal and synaptic preparations. Most of these observations can be explained by a use- and frequency-dependent suppression of the sodium action potential by phenytoin, with a consequent filtering out of sustained high-frequency neuronal discharges and synaptic activity. The molecular mechanism for this is a voltage-dependent blockade of membrane sodium channels responsible for the action potential. Through this action, phenytoin obstructs the positive feedback that underlies the development of maximal seizure activity, while normal brain activity, proceeding at lower neuronal firing rates, is spared its depressant action. Other mechanisms of action that may contribute to the drug's efficacy and selectivity are also discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428283     DOI: 10.1002/ana.410200202

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  27 in total

1.  The critical role of persistent sodium current in hippocampal gamma oscillations.

Authors:  Young-Jin Kang; Ethan M Clement; Stefan L Sumsky; Yangfei Xiang; In-Hyun Park; Sabato Santaniello; Lazar John Greenfield; Edgar Garcia-Rill; Bret N Smith; Sang-Hun Lee
Journal:  Neuropharmacology       Date:  2019-09-21       Impact factor: 5.250

2.  Phenytoin: a step by step insight into its multiple mechanisms of action-80 years of mechanistic studies in neuropharmacology.

Authors:  Jan M Keppel Hesselink
Journal:  J Neurol       Date:  2017-03-27       Impact factor: 4.849

3.  Neuroleptic malignant syndrome induced by phenytoin in a patient with drug-induced Parkinsonism.

Authors:  Hae-Won Shin; Young Chul Youn
Journal:  Neurol Sci       Date:  2014-05-29       Impact factor: 3.307

4.  An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons.

Authors:  P Calabresi; D Centonze; G A Marfia; A Pisani; G Bernardi
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  The effect of diphenylhydantoin on the electroretinogram.

Authors:  P Lachapelle; L Blain; M G Quigley; R C Polomeno; S Molotchnikoff
Journal:  Doc Ophthalmol       Date:  1989-12       Impact factor: 2.379

6.  Effect of chronic administration of phenytoin on regional monoamine levels in rat brain.

Authors:  M H Meshkibaf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

Review 7.  Effects of antiepileptic drugs on antioxidant and oxidant molecular pathways: focus on trace elements.

Authors:  Mustafa Nazıroğlu; Vedat Ali Yürekli
Journal:  Cell Mol Neurobiol       Date:  2013-04-14       Impact factor: 5.046

8.  Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission.

Authors:  M F Mehler; K Z Haas; J A Kessler; P K Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Electrophysiological actions of felbamate on rat striatal neurones.

Authors:  A Pisani; A Stefani; A Siniscalchi; N B Mercuri; G Bernardi; P Calabresi
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews.

Authors:  A M Magariños; B S McEwen; G Flügge; E Fuchs
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.